Description
TICAGREL Tablet 14’s ticagrelor, a potent antiplatelet medication, is the active ingredient in ticagrelor tablet 14’s. These tablets are designed to reduce the risk of blood clots forming after a heart attack or stroke, particularly for individuals who have undergone percutaneous coronary intervention (PCI). By inhibiting the platelet P2Y12 receptor, Ticagrelor Tablet 14’s help prevent harmful blood clots from forming and causing further cardiovascular events. This medication is an essential component of secondary prevention strategies for patients with a history of heart disease. Consult your healthcare provider for dosage and usage instructions.
Reviews
There are no reviews yet.